Amedisys Pre-Tax Profit Margin 2010-2024 | AMED

Amedisys pre-tax profit margin from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Amedisys Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-03-31 $2.25B $0.03B 1.42%
2023-12-31 $2.24B $0.04B 1.79%
2023-09-30 $2.23B $0.05B 2.33%
2023-06-30 $2.23B $0.05B 2.20%
2023-03-31 $2.23B $0.15B 6.76%
2022-12-31 $2.22B $0.16B 7.20%
2022-09-30 $2.22B $0.17B 7.48%
2022-06-30 $2.22B $0.19B 8.44%
2022-03-31 $2.23B $0.26B 11.50%
2021-12-31 $2.23B $0.28B 12.57%
2021-09-30 $2.23B $0.30B 13.26%
2021-06-30 $2.22B $0.30B 13.55%
2021-03-31 $2.16B $0.24B 10.97%
2020-12-31 $2.11B $0.21B 9.97%
2020-09-30 $2.05B $0.19B 9.12%
2020-06-30 $2.00B $0.17B 8.47%
2020-03-31 $1.98B $0.17B 8.48%
2019-12-31 $1.96B $0.17B 8.64%
2019-09-30 $1.89B $0.17B 8.84%
2019-06-30 $1.81B $0.16B 9.06%
2019-03-31 $1.73B $0.16B 9.48%
2018-12-31 $1.66B $0.16B 9.57%
2018-09-30 $1.63B $0.15B 9.29%
2018-06-30 $1.58B $0.13B 8.46%
2018-03-31 $1.55B $0.09B 6.02%
2017-12-31 $1.51B $0.08B 5.36%
2017-09-30 $1.46B $0.07B 4.58%
2017-06-30 $1.45B $0.06B 4.21%
2017-03-31 $1.44B $0.08B 5.29%
2016-12-31 $1.42B $0.06B 4.37%
2016-09-30 $1.41B $0.07B 4.96%
2016-06-30 $1.37B $0.07B 4.88%
2016-03-31 $1.33B $0.07B 5.05%
2015-12-31 $1.28B $-0.00B 0.00%
2015-09-30 $1.24B $-0.01B -0.64%
2015-06-30 $1.22B $-0.01B -0.74%
2015-03-31 $1.21B $-0.02B -1.24%
2014-12-31 $1.21B $0.02B 1.74%
2014-09-30 $1.21B $-0.01B -0.66%
2014-06-30 $1.21B $-0.17B -14.07%
2014-03-31 $1.22B $-0.18B -14.68%
2013-12-31 $1.25B $-0.15B -12.33%
2013-09-30 $1.29B $-0.29B -22.81%
2013-06-30 $1.35B $-0.13B -9.76%
2013-03-31 $1.40B $-0.12B -8.65%
2012-12-31 $1.44B $-0.12B -7.98%
2012-09-30 $1.42B $0.05B 3.74%
2012-06-30 $1.42B $-0.52B -36.38%
2012-03-31 $1.43B $-0.49B -34.57%
2011-12-31 $1.42B $-0.48B -33.66%
2011-09-30 $1.46B $-0.44B -29.97%
2011-06-30 $1.49B $0.16B 10.45%
2011-03-31 $1.55B $0.17B 11.05%
2010-12-31 $1.60B $0.20B 12.68%
2010-09-30 $1.62B $0.22B 13.43%
2010-06-30 $1.60B $0.24B 15.01%
2010-03-31 $1.56B $0.25B 15.76%
2009-12-31 $1.48B $0.23B 15.43%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.145B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.537B 10.61
Quest Diagnostics (DGX) United States $15.695B 16.22
DaVita (DVA) United States $12.150B 15.09
Encompass Health (EHC) United States $8.507B 21.78
Chemed (CHE) United States $8.408B 26.06
Elanco Animal Health (ELAN) United States $8.297B 21.53
Option Care Health (OPCH) United States $5.048B 19.11
RadNet (RDNT) United States $4.325B 90.06
Astrana Health (ASTH) United States $2.239B 30.28
LifeStance Health (LFST) United States $2.179B 0.00
Addus HomeCare (ADUS) United States $1.827B 26.14
U.S Physical Therapy (USPH) United States $1.534B 41.06
Pennant (PNTG) United States $0.706B 37.29
Aveanna Healthcare Holdings (AVAH) United States $0.539B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00